Clinical Trial Update: A Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Abalparatide Injection and the Reference Formulation Abalparatide Injection (Tymlos®) in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1, single-center, open-label, randomized, single-dose cross-over bioequivalence study to compare a test formulation of Abalparatide Injection with the ref…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Abalparatide Injection (Tymlos reference) (abalparatide)
• Abalparatide Injection (test formulation) (abalparatide)

Snippet

Sponsor: The Affiliated Hospital of Qingdao University | Conditions: Osteoporosis | Phase 1 | Status: NOT_YET_RECRUITING